These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16233926)

  • 1. Amyloidogenecity and pitrilysin sensitivity of a lysine-free derivative of amyloid beta-peptide cleaved from a recombinant fusion protein.
    Cornista JC; Koga Y; Takano K; Kanaya S
    J Biotechnol; 2006 Mar; 122(2):186-97. PubMed ID: 16233926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of amyloid beta fragments in aqueous environments.
    Takano K; Endo S; Mukaiyama A; Chon H; Matsumura H; Koga Y; Kanaya S
    FEBS J; 2006 Jan; 273(1):150-8. PubMed ID: 16367755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and purification of a recombinant peptide from the Alzheimer's beta-amyloid protein for solid-state NMR.
    Sharpe S; Yau WM; Tycko R
    Protein Expr Purif; 2005 Jul; 42(1):200-10. PubMed ID: 15939307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification and characterization of a synthetic gene encoding human amyloid beta (Abeta1-42) in Escherichia coli.
    Subramanian S; Shree AN
    Indian J Biochem Biophys; 2007 Apr; 44(2):71-5. PubMed ID: 17536333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of recombinant amyloid-beta peptide 42 as an ubiquitin extension.
    Lee EK; Hwang JH; Shin DY; Kim DI; Yoo YJ
    Protein Expr Purif; 2005 Mar; 40(1):183-9. PubMed ID: 15721787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification, and characterization of recombinant human beta-amyloid42 peptide in Escherichia coli.
    Zhang L; Yu H; Song C; Lin X; Chen B; Tan C; Cao G; Wang Z
    Protein Expr Purif; 2009 Mar; 64(1):55-62. PubMed ID: 18996484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological effects of immune serum from fusion protein of beta-amyloid peptide and HbcAg/MIR on AD transgeneic cells].
    Liu ZH; Feng GF; Li YY; Ma YB; Hu HT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):608-12. PubMed ID: 17718422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizations of distinct amyloidogenic conformations of the Abeta (1-40) and (1-42) peptides.
    Lim KH; Collver HH; Le YT; Nagchowdhuri P; Kenney JM
    Biochem Biophys Res Commun; 2007 Feb; 353(2):443-9. PubMed ID: 17184733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of Abeta42 into a folded soluble native-like protein using a semi-random library of amphipathic helices.
    Arslan PE; Mulligan VK; Ho S; Chakrabartty A
    J Mol Biol; 2010 Mar; 396(5):1284-94. PubMed ID: 20026077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fusion expression of human Abeta42 recombinant protein and detection of Abeta antibody].
    Zhang G; Wang LF; Wang HQ; Yao ZB
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):160-4. PubMed ID: 15698994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural, thermodynamic, and mutational analyses of a psychrotrophic RNase HI.
    Tadokoro T; You DJ; Abe Y; Chon H; Matsumura H; Koga Y; Takano K; Kanaya S
    Biochemistry; 2007 Jun; 46(25):7460-8. PubMed ID: 17536836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution.
    Dai XL; Sun YX; Jiang ZF
    FEBS Lett; 2007 Apr; 581(7):1269-74. PubMed ID: 17349630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.
    Grönwall C; Jonsson A; Lindström S; Gunneriusson E; Ståhl S; Herne N
    J Biotechnol; 2007 Jan; 128(1):162-83. PubMed ID: 17088007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interface peptide of Alzheimer's amyloid beta: application in purification.
    Das U; Hariprasad G; Pasha S; Mann A; Ganguli M; Sharma S; Kaur P; Singh TP; Srinivasan A
    Biochem Biophys Res Commun; 2007 Oct; 362(2):538-42. PubMed ID: 17707778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta.
    Cynis H; Scheel E; Saido TC; Schilling S; Demuth HU
    Biochemistry; 2008 Jul; 47(28):7405-13. PubMed ID: 18570439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
    Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.